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Use antibiotics in cell culture 
with caution: genome-wide 
identification of antibiotic-induced 
changes in gene expression and 
regulation
Ann H. Ryu1,2, Walter L. Eckalbar1,2, Anat Kreimer1,3, Nir Yosef  3,4 & Nadav Ahituv  1,2
Standard cell culture guidelines often use media supplemented with antibiotics to prevent cell 
contamination. However, relatively little is known about the effect of antibiotic use in cell culture on 
gene expression and the extent to which this treatment could confound results. To comprehensively 
characterize the effect of antibiotic treatment on gene expression, we performed RNA-seq and 
ChIP-seq for H3K27ac on HepG2 cells, a human liver cell line commonly used for pharmacokinetic, 
metabolism and genomic studies, cultured in media supplemented with penicillin-streptomycin 
(PenStrep) or vehicle control. We identified 209 PenStrep-responsive genes, including transcription 
factors such as ATF3 that are likely to alter the regulation of other genes. Pathway analyses found a 
significant enrichment for “xenobiotic metabolism signaling” and “PXR/RXR activation” pathways. 
Our H3K27ac ChIP-seq identified 9,514 peaks that are PenStrep responsive. These peaks were enriched 
near genes that function in cell differentiation, tRNA modification, nuclease activity and protein 
dephosphorylation. Our results suggest that PenStrep treatment can significantly alter gene expression 
and regulation in a common liver cell type such as HepG2, advocating that antibiotic treatment should 
be taken into account when carrying out genetic, genomic or other biological assays in cultured cells.
One of the most common cautionary measures taken during in vitro studies is the use of antibiotics while cultur-
ing cells in order to avoid bacterial contamination. Standard cell culture protocols listed by the American Type 
Culture Collection (ATCC) explicitly entail the addition of antibiotics, such as penicillin-streptomicin (PenStrep) 
and gentamicin, as media supplements1. Many large-scale genomic projects, such as the ENCODE project2, use 
cell lines in order to understand the diversity of gene expression and regulatory profiles across human cell types 
and require the routine use of antibiotics in their protocols. The implicit assumption made within the community 
is that using antibiotics in cell culture has a negligible impact on gene expression.
Previous studies have demonstrated that changes in gene expression and regulation in vitro can be induced 
by antibiotics3, 4. One study has even shown that antibiotics such as rifampin can induce genome-wide, 
drug-dependent changes in gene regulation and expression patterns in human hepatocytes. However, the molec-
ular consequences of growing human cells with antibiotics at standard cell culture concentrations have yet to be 
thoroughly investigated.
Penicillin is a group of antibiotics metabolized in the liver that eliminate bacteria by inhibiting the peptidogly-
can synthesis necessary to maintain the bacterial cell wall5. Streptomycin is an antibiotic that acts as a protein syn-
thesis inhibitor by binding to the small 16 S rRNA of the 30 S subunit of the bacterial ribosome, interfering with 
codon reading and ultimately the death of microbial cells through mechanisms that are still not well understood6. 
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Although streptomycin is used in combination with penicillin in standard antibiotic cocktails to prevent bacterial 
infection in cell culture, their mechanism of action in cells other than microbial cells are not well understood. In 
order to investigate the effects of antibiotics commonly used in cell culture on gene expression and regulation, 
we performed RNA-seq and H3K27ac ChIP-seq on HepG2 cells, immortalized human liver cells, treated with 
or without PenStrep. We identified a set of differentially expressed genes responsive to PenStrep that was signifi-
cantly enriched for pathways involved in drug metabolism and known pathways induced by gentamicin, another 
commonly used antibiotic in cell culture. ChIP-seq for H3K27ac, an active promoter and enhancer mark7, 8, 
identified thousands of PenStrep responsive peaks. Combined, our study elucidates genes and regulatory regions 
that are activated due to antibiotic treatment in liver cells, and suggests that the use of antibiotics in genomic and 
other biological studies should be taken into account in any type of analysis.
Results
Drug-associated genes are differentially expressed following PenStrep treatment. To system-
atically identify genes that are differentially expressed due to culturing cells with antibiotics, we compared gene 
expression levels of HepG2 cells cultured with standard 1% PenStrep-supplemented media and HepG2 cells cul-
tured with media not supplemented with PenStrep (Fig. 1). Using DESeq2 to perform differential expression 
analysis9, we identified 209 differentially expressed (DE) genes using a q-value cutoff after adjustment for mul-
tiple testing of less than or equal to 0.1 and validated expression of a subset of DE genes via RT-qPCR (Fig. 2a, 
Supplementary Table S1, Supplementary Fig. S1). Amongst these DE genes, 157 were significantly upregulated 
due to PenStrep treatment and 52 were downregulated (Fig. 1). These include a set of transcription factors- ATF3, 
SOX4, FOXO4, TGIF1, HOXD1, FOXC1, GTF3C6 – some of which are known to play a significant role in drug 
and stress response4, 10–23. Pathway analysis using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID;24) found that the cluster of 157 DE genes that were upregulated due to PenStrep are enriched 
for gene ontology terms associated with apoptosis (p-value = 1.91E-05), drug response (p-value = 1.58E-04), 
unfolded protein response (p-value = 3.84E-04), and nitrosative stress (p-value = 3.98E-04) (Fig. 2a). DE genes 
that were downregulated in response to PenStrep were enriched for gene ontology categories related to insulin 
response (p-value = 6.85E-04), cell growth and proliferation (p-value = 0.012), toxic substance (p-value = 0.018), 
as well as drug response (p-value = 0.012) (Fig. 2a). Further analyses of PenStrep DE genes using Ingenuity path-
way analysis (IPA), found canonical pathway enrichment for PXR/RXR activation (p-value = 9.43E-05), a known 
drug response pathway associated with antibiotic treatment25 (Fig. 2b). Further IPA analyses for upstream regula-
tors enriched for DE genes, identified a significant enrichment for gentamicin (p-value = 2.93E-13), an aminogly-
coside (like streptomycin) that is associated with nephrotoxicity as well as ototoxicity in human patients26–28 but 
also commonly used in cell culture on target genes (Fig. 2b and c). The overlap between target genes of gentamicin 
and the PenStrep-dependent genes in our analysis demonstrates a similar mechanism of action across antibiotics 
in human cells. Overall, the diversity of gene pathways activated in PenStrep-treated cells not only suggests that 
PenStrep induces a systemic change in gene expression in human cell lines, but that PenStrep may also be induc-
ing broader changes at the gene regulatory level.
PenStrep induces differential enrichment of active promoter and enhancer regions marked by 
H3K27ac. To determine whether culturing cells with PenStrep also leads to chromatin landscape changes 
that can alter gene regulation, we performed ChIP-seq for H3K27ac on both HepG2 cells cultured with and 
without PenStrep. Using DESeq29, we annotated a total of 9,514 peaks that are differentially enriched between 
PenStrep and control treatments at a q-value cutoff, after adjustment for multiple testing, of less than or equal to 
0.1 (Supplementary Table S2). Of these peaks, 5,087 were highly enriched in the PenStrep condition and 4,427 
peaks were highly enriched in the control treatment (Fig. 1 and Fig. 3a). Using the Genomic Regions Enrichment 
Figure 1. Experimental design. Schematic of the RNA-seq and ChIP-seq assays performed on HepG2 cells 
treated with and without PenStrep. The number of differentially expressed genes and differentially enriched 
H3K27ac peaks are listed in the table below the diagram.
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Annotation Tool (GREAT;29), we identified genes nearby each cluster of DE regions separately (up or down) 
for gene ontology enrichment. For the cluster of enriched H3K27ac peaks induced by PenStrep, we observed 
a significant association with genes involved in tRNA modification (p-value = 2.0E-08), regulation of nuclease 
activity (p-value = 2.0E-08), cellular response to misfolded protein (p-value = 1.1E-07), and regulation of pro-
tein dephosphorylation (p-value = 1.9E-07) (Fig. 3a). As streptomycin is known to act as a protein synthesis 
inhibitor by binding to the small 16 S rRNA of the 30 S subunit of the bacterial ribosome, this suggests that the 
known mechanism of action for streptomycin in bacterial cells may also affect mammalian cells6, 30. For the cluster 
of H3K27ac peaks that were significantly enriched in the control treatment, GREAT identified an enrichment 
for genes involved in stem cell differentiation (p-value = 6.8E-22), actin depolymerization (p-value = 1.3E-21), 
negative regulation of transcription factor activity (p-value = 2.0E-19), response to reactive oxygen species and 
positive regulation of cell cycle (p-value = 1.2E-14) (Fig. 3a). Combined, our results demonstrate a global change 
in the regulatory landscape induced by PenStrep that corroborate some of the gene pathways enriched in our 
RNA-seq results as well as toxicity pathways that are associated with streptomycin.
Figure 2. RNA-seq analysis on HepG2 cells cultured with and without PenStrep. (A) Shown in the top left is a 
heatmap depicting relative expression levels for all 209 differentially expressed genes across all three replicates 
per treatment. To the right of each cluster, the top gene ontology terms as determined by DAVID v6.824 are 
shown. (B) PenStrep DE genes canonical pathways and upstream regulators with the top five highest binomial 
fold enrichment values and most significant p-values as determined by IPA. (C) IPA network analysis for 
gentamicin, one of the top most significant upstream regulators for PenStrep DE genes. This network is drawn 
based on calculated z-scores for published gene expression patterns under gentamicin as determined by IPA.
www.nature.com/scientificreports/
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PenStrep-responsive regulatory regions overlap or reside near PenStrep-associated genes. In 
order to test for a correlation between the DE H3K27ac peaks and DE genes found via ChIP-seq and RNA-seq 
respectively, we took all 9,514 DE regions and matched the closest gene expressed (i.e. had a normalized FPKM 
greater than zero across replicates for all conditions). We found a positive Spearman correlation between regions 
having a DE H3K27ac signal and expression of DE genes that are enriched in the PenStrep condition (r = 0.21) 
as well as a positive Spearman correlation between DE H3K27ac regions and DE genes that are depleted in the 
PenStrep condition (r = 0.15). Additionally, we performed hyper geometric tests on matching clusters of PenStrep 
Figure 3. ChIP-seq analysis of PenStrep responsive peaks in HepG2 cells. (A) The top right panel shows a 
heatmap depicting z-scores as relative expression levels normalized to input per peak for all 9,514 differentially 
enriched H3K27ac peaks across all three replicates per treatment. To the right, are shown the top region-gene 
association pathways according to GREAT29. (B) Integrative genomic viewer snapshot showing RNA-seq and 
H3K27ac ChIP-seq results in the ATF3 locus. The scale for the RNA-seq tracks was normalized per million 
mapped reads (e.g. coverage/(total mapped reads/1 M)). The vertical scale for the ChIP-seq tracks is set to a 
scale of zero to one, with zero defined as the median coverage of the genome and one defined as the top (99.9th) 
percentile of reads counted in any given 100 bp window. This locus shows increased ATF3 expression in the 
PenStrep- treated HepG2 cells (red) versus vehicle control treated cells (blue) observed through RNA-seq, as 
well as ChIP-based enrichment of H3K27ac in PenStrep-treated cells (red) versus vehicle control treated cells 
(blue).
www.nature.com/scientificreports/
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dependent DE genes and DE H3K27ac regions in order to determine significance of enrichment of DE genes 
within DE H3K27ac regions (Supplementary Table S3). We found that the cluster of DE genes and DE H3K27ac 
regions that are up in PenStrep have significant overlap (p-value = 1.21E−07). Conversely, the cluster of DE genes 
and DE H3K27ac regions that are downregulated in PenStrep also have significant overlap (p-value = 2.75E−08). 
These findings corroborate the overlapping gene ontology term enrichments found for both our RNA-seq and 
ChIP-seq DE genes and peaks. GO terms related to misfolded protein response were found for both clusters of 
genes and H3K27ac peaks that showed an increase upon PenStrep treatment (Fig. 2a and Fig. 3a). Similarly, the 
clusters of DE genes and H3K27ac peaks that were depleted upon PenStrep treatment show GO term enrichment 
for cell cycle regulation and cell growth. Our findings also further validate some of the known mechanisms of 
action for antibiotics and their potential impact on regulatory and gene expression patterns. One of the known 
mechanisms of inactivation common to all classes of antibiotics is the stimulated production of lethal doses of 
hydroxyl radicals via the Fenton reaction31. Previous studies have shown that aminoglycoside antibiotics can 
induce cell death by causing the generation of highly destructive hydroxyl radicals32. This link between oxidative 
stress and drug response is also observed in the significant correlation between clusters of DE peaks and DE 
genes in our data, both of which demonstrate GO terms related to “reactive oxygen species” and “drug response”, 
respectively. Many of these DE H3K27ac regions were found to overlap DE genes that are transcription factors, as 
is underscored by enrichment of regions near genes important for transcription factor activity found through our 
GREAT analysis (Fig. 3a). One notable example of this is ATF3, which is more highly expressed in the PenStrep 
condition and has a regulatory region that is also enriched in the PenStrep condition that overlaps its third exon 
(Fig. 3b). ATF3 is a transcription factor that is known to play a role in pathways underlying cell differentiation 
and proliferation33–36, response to unfolded proteins37, inflammation and immune response38–40, and regulating 
hepatic gluconeogenesis and insulin resistance41–45. ATF3 is also known to be a major player in drug response4, 10–16. 
Combined, our results show correlation between DE regulatory elements and DE genes and highlight several 
pathways and genes that could be associated with PenStrep response.
Discussion
Standard protocols for cell culture frequently require antibiotics to reduce contamination. Amongst the most 
popular antibiotics used for cell culture are gentamicin and PenStrep, a cocktail of both penicillin and streptomy-
cin. Streptomycin and gentamicin are both aminoglycosides, a family of antibiotics that is well known to induce 
nephrotoxicity26–28 as well as ototoxicity in patients. Despite their known toxicity in humans, there have been only 
a few reports that have demonstrated how these antibiotics impact gene expression. These studies have shown 
the impact of protein synthesis and enzyme activity in rat cell cultures46–48 and that these antibiotics produce side 
effects during human stem cell differentiation into adipocytes30. However, the systematic effects of using these 
antibiotics at the standard cell culture concentrations on gene expression and regulation in human cell lines have 
not been thoroughly investigated30. Here, by carrying out RNA-seq and ChIP-seq on PenStrep and vehicle treated 
HepG2 cells, we show that antibiotics can induce a global change in gene expression and chromatin landscape in 
a human cell line.
We find that PenStrep responsive genes are not only involved in pathways related to drug response, but also 
to insulin response, fatty acid activation, mitochondrial l-carnitine shuttle pathways, apoptosis, cell growth, and 
unfolded protein response. We also observe that many of these PenStrep-dependent DE genes are also known 
targets of gentamicin, some of which are nuclear receptors and transcription factors (e.g. ATF3). Gentamicin 
and other members of the aminoglycoside family, such as streptomycin, are associated with both nephrotoxicity 
and ototoxicity in humans26, 27. However, the molecular mechanisms underlying death of proximal tubule kidney 
cells and mechanosensory hair cells due to aminoglycosides are not well understood28. Given that both types of 
toxicity have been associated with most aminoglycosides, streptomycin could be an activator of toxicity pathways 
across cell types. The overlap of PenStrep-activated DE genes with known targets of gentamicin suggests that 
toxicity pathways known to be induced by antibiotics could exist not only in microbial cells and human patients, 
but also in human cells in vitro. Furthermore, our results may also reveal some patterns in gene expression and 
regulatory regions underlying toxicity pathways induced by aminoglycosides as a group.
Changes in gene expression were further corroborated by changes in regulatory regions observed in our 
H3K27ac ChIP-seq data from the same PenStrep treatment of HepG2 cells. Not only was there significant overlap 
between DE regions found in our H3K27ac data, but when we looked at genes nearby DE regions dependent 
on PenStrep treatment, we found enrichment for several similar pathways. Regulation of cell cycle and cellu-
lar response to misfolded protein reappeared as potential pathways regulated by H3K27ac regions activated by 
PenStrep. Some pathways based on H3K27ac DE region-gene associations were reminiscent of the known mech-
anism of action of streptomycin in bacteria, such as tRNA modification. Other pathways found to be enriched in 
our DE region-gene associations, such as response to reactive oxygen species and cytoskeleton depolymerization, 
were previously shown to be disrupted by antibiotics in the differentiation of human stem cells into adipocytes30 
and mouse embryonic stem cells into neurons49. The recapitulation of pathways disrupted by antibiotics at stand-
ard cell culture concentrations in mouse stem cells, human stem cells, human adipocytes and the human liver 
cell line we used for this study, suggests that the mechanism of action of antibiotics is likely to be detectable and 
similarly perturbed across other human cell lines commonly used for research.
Several transcription factors were also observed to have enhanced expression due to PenStrep treatment, 
which could potentially alter the expression of additional genes and pathways. Some of these transcription factors 
are known to be key regulators of differentiation, drug response, and cell cycle and growth. One of the most nota-
ble transcription factors amongst our observed PenStrep –dependent genes, is ATF3, a transcriptional repressor 
that is known to play a role in cell differentiation and proliferation33–36, the unfolded protein response37, inflamma-
tion and immune response38–40, hepatic gluconeogenesis and insulin resistance41–45, as well as drug response4, 10–16. 
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ATF3 is well-studied in a wide diversity of human cell types including hepatocytes, activated T-cells, skeletal 
muscle cells, macrophages, as well as cancer cell lines and immortalized cell lines. In our study, we find that 
ATF3 expression is dependent on PenStrep and that it contains a PenStrep dependent regulatory region that 
may compound the regulatory effect of ATF3 accessibility and expression. Given that ATF3 expression may be 
significantly enhanced by PenStrep treatment, studies that examine ATF3’s role in pathways related to toxicity, cell 
proliferation and differentiation should avoid use of antibiotics in cell culture if possible. The impact of culturing 
liver cells with antibiotics, as shown in our study on HepG2 cells, could also apply to other immortalized human 
cell lines that are commonly used to assess gene expression patterns at baseline and in drug-induced conditions 
and even primary cells. It is possible that antibiotics such as penicillin-streptomycin and gentamicin also induce a 
functional state that is significantly different from the basal state of these cell types. Further evaluation of the bio-
logical impact of antibiotic treatment across cell lines is highly warranted. We provide some evidence that using 
antibiotics in cell culture should be avoided- especially in studies focused on drug response as well as cell cycle 
regulation, differentiation, and growth. Data from studies in which antibiotics are used for cell culture should be 
examined with caution.
Methods
HepG2 cell culture. HepG2 cells (ATCC) were thawed at passage 37 and cultured in two separate batches 
with D-MEM, high glucose media (catalog # 11965-092, Life Technologies) that contained fetal bovine serum 
(catalog # CCFAP003, UCSF Cell Culture Facility) at 10%, L-glutamine (catalog # CCFGB002, UCSF Cell Culture 
Facility) at 1% in 6-well plates (catalog # 3516, Corning). One batch was cultured with this DMEM media supple-
mented with penicillin-streptomycin (catalog # CCFGK003, UCSF Cell Culture Facility) at the standard ATCC 
guideline of 1%. The other batch that served as the control group, was cultured in parallel in DMEM media that 
was not supplemented with penicillin-streptomycin and incubated at 37 degrees Celsius, 5% CO2 for two passages 
(or 21 days post-thaw).
RNA-seq. HepG2 cells were cultured with PenStrep-supplemented media or control media in separate batches 
as mentioned above. The cells were then washed with PBS, and lysed directly with Buffer RLT from the RNAeasy 
mini kit (Qiagen) with the on-column DNase digestion step for collecting total RNA. Libraries were made with 
Illumina NGS library preparation for polyA tail selection on 5 ug of total RNA per sample by the UCSF Genomic 
Core Laboratories (http://humangenetics.ucsf.edu/genomics-services/). Three technical replicates were carried 
out for each condition. 50 bp single end sequencing was carried out on an Illumina Next-Generation Sequencing 
platform. The resulting reads were demultiplexed and aligned to the human genome (hg19) using STAR50, which 
also calculated read counts for each gene in the Ensembl annotation. Analysis for differential expression across 
the six replicates was performed using DESeq. 29. DESeq. 2 was chosen due to its stringency in normalization and 
distribution methods. Gene expression data was filtered based on outlier detection, low counts, and no counts per 
gene. Gene ontology terms per RNA-seq cluster of DE genes were assessed using DAVID24.
Quantitative PCR validation. Cultured HepG2 cells were washed with PBS, and lysed directly with Buffer 
RLT from a Qiagen RNAeasy mini kit with the on-column DNAseq digestion step. One µg of total RNA was used 
to generate cDNA using the RT2 First Stand Kit (Qiagen). Gene expression levels for 84 genes were determined 
using the “Drug Metabolism: Phase I Enzymes” RT2 Profiler PCR Array (Qiagen). Out of these 84 genes, we cal-
culated fold change expression levels for 9 genes that were DE in our RNA-seq dataset. Five housekeeping genes 
(B2m, HPRT1, RPL13A, GAPDH, ACTB) were used to control for loading. Fold induction was calculated using 
the Δ Δ Ct method.
Ingenuity pathway analysis. Ensembl Gene IDs and the log2FoldChange for the differentially expressed 
(DE) genes from our RNA-seq were uploaded into QIAGEN’s Ingenuity Pathway Analysis (IPA, QIAGEN 
Redwood City, http://www.ingenuity.com/). We used the following IPA core analysis settings: general settings, 
reference set = Ingenuity knowledge base (genes only), relationships to consider = direct and indirect relation-
ships; data sources = all; confidence = experimentally observed only. We reviewed Ingenuity canonical pathways 
to study known biological pathways and processes of interest that were enriched in our DE genes. We also used 
the Ingenuity upstream analysis, which predicts the functional status of upstream regulators, such as transcription 
factors, kinases, and growth factors based on known downstream targets, i.e., the input set of the DE genes.
ChIP-seq. Around twelve million cells were cultured separately from the RNA-seq experiments but in iden-
tical conditions as previously mentioned (37 °C, 5% CO2 for two passages) on 6 well plates. For each immuno-
precipitation, one plate was fixed with 1% formaldehyde for 15 minutes and quenched with 0.125 M glycine. The 
remainder of the ChIP-seq protocol was carried out using the Diagenode LowCell# ChIP kit (Diagenode; catalog 
number: C01010070) following the manufacturer’s protocol. Chromatin was isolated by adding lysis buffer and 
sheared to an average length of 300 bp with a Covaris sonicator. Genomic DNA regions of interest were iso-
lated using 4 ug of antibody against H3K27ac (Abcam; catalog number ab4729). Genomic DNA complexes were 
washed, eluted from the beads with SDS buffer, and subjected to RNase and proteinase K treatment. Crosslinks 
were reversed by incubation at 65 °C, and ChIP DNA was subsequently isolated and purified. Three technical 
replicates were carried out for each condition. Input genomic DNA was prepared by treating aliquots of chro-
matin with RNase, proteinase K and heat for de-crosslinking, followed by ethanol precipitation. Pellets were 
resuspended and the resulting DNA was quantified on a Bioanalyzer. ChIP and input DNAs were prepared for 
amplification using a ThruPLEX DNA-seq kit (Rubicon Genomics) following the manufacturer’s protocol. Library 
barcode adaptors were added to each sample during amplification and the library was size-selected (~150–200 bp) 
using a Diagenode iPure kit v2. The resulting amplified DNA was purified, quantified, and tested by a Bioanalyzer 
reading to assess the quality of the amplification reactions. Amplified DNA libraries were sequenced on and 
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Illumina HiSeq. 4000. All reads were mapped to the human genome using Bowtie51. H3K27ac peaks were called 
against input using MACS52 and peaks consistent across replicates identified using the ENCODE Irreproducibility 
Discovery Rate (IDR) pipeline53. For differential peak intensity analysis, peaks across conditions were merged and 
reads coverage obtained using HTSeq.54. H3K27ac peaks differentially enriched in the PenStrep condition were 
then identified through DESeq. 29 using a custom normalization matrix to correct for differing signal to noise 
ratios between replicates55. The mean number of normalized counts per region was calculated across all replicates 
in both conditions. The difference between the mean and the normalized counts per regions (corrected for signal 
to noise ratios) was used as a z-score for visualizing differential H3K27ac peak enrichment. As with the RNA-seq 
analysis, PenStrep dependent regions were identified through clustering analysis on all differentially enriched 
H3K27ac regions with adjusted p-values (FDR) < 0.1 between the PenStrep-treated and non-treated conditions 
using the R package hclust and displayed in a heatmap.
Annotation of ChIP-seq genomic regions. Genes predicted to interact with the H3K27ac regions found 
to be up-regulated or down-regulated in the presence of PenStrep were annotated using GREAT v3.0.029. Bed 
files were generated for differentially active H3K27ac peaks that were up-regulated in the control condition or 
up-regulated in the PenStrep condition. These bed files were then used as input test files with the human reference 
genome, assembly GRCh37 (UCSC hg19, Feb/2009) set as the background.
Cluster enrichment Analysis. To compare PenStrep dependent clusters of DE regions and DE genes, we 
used all 9,514 DE regions from the H3K27ac analysis and matched the closest gene expressed that had a nor-
malized FPKM value > 0 for all replicates across conditions. We cluster these regions into two groups (control/
PenStrep dependent regions). Similarly, we cluster all DE genes (control/PenStrep responsive genes). We then test 
for Spearman’s correlation between H3K27ac signal in DE regions and RNA-seq signal in DE genes from these 
clusters and report the hypergeometric test enrichment p-values to determine the significance of overlap between 
PenStrep-dependent DE genes and regions.
Data Availability. RNA-seq raw data is publicly available in the NCBI Sequence Reads Archive under 
Bioproject PRJNA357649. ChIP-seq bam files are publicly available in the NCBI Sequence Reads Archive under 
Bioproject PRJNA357650.
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